CUMULATIVE MARKET VALUE OVER $200 BILLION Planned* pharmacokCUMULATIVE MARKET VALUE OVER $200 BILLION Planned* pharmacokinetic (“PK”) studies will evaluate ability to improve quantity of drug delivered and speed with which it is delivered, in all of these areas: Details to be announced and subject to change and scheduling (1) https://www.globenewswire.com/en/news-release/2021/06/01/2239293/0/en/Global-Cannabidiol-CBD-Market-Size-to-Grow-at-a-CAGR-of-51-from-2021-to-2030.html (2) https://www.globenewswire.com/en/news-release/2021/05/17/2230401/28124/en/Insights-on-the-87-Billion-Cardiovascular-Drugs-Global-Market-to-2030-Identify-Growth-Segments-for-Investment.html (3) https://www.reportlinker.com/p06090622/AntiviralsGlobal-Market-Report-COVID-19-Implications-And-Growth-to.html?utm_source=GNW (4) https://www.thebusinessresearchcompany.com/report/cannabis-products-global-market-report (5) https://www.grandviewresearch.com/industry-analysis/hormonereplacement-therapy-market (6) https://www.fortunebusinessinsights.com/non-steroidal-anti-inflammatory-drugs-nsaids-market-102823 (7) https://www.grandviewresearch.com/industry-analysis/smokeless-tobacco-products-market (8) https://www.grandviewresearch.com/industry-analysis/erectile-dysfunction-drugs-market (9) https://www.globenewswire.com/en/news-release/2021/05/04/2221987/0/en/Nicotine-Replacement-Therapy-Market-Size-2021-Is-Projected-to-Reach-USD-3-92- Billion-by-2028-Exhibiting-a-CAGR-of-4-3.html (10) https://www.marketdataforecast.com/market-reports/vitamin-d-market NASDAQ:LEXX | NASDAQ:LEXXW Size Future Size Markets US $bn Year US $bn Year CBD(1) 2.7 2021 111.0 2030 Cardiovascular Drugs(2) 87.8 2020 107.8 2025 Antivirals(3) 52.1 2021 66.7 2025 Oral Cannabinoid(4) 18.4 2021 46.2 2025 Human Hormones(5) 21.9 2019 26.8 2022 NSAIDs(6) 15.6 2019 24.4 2027 Oral Mucosal Nicotine(7) 13.6 2018 22.1 2025 PDE5 Inhibitors(8) 4.4 2014 5.3 2022 Nicotine Replacement(9) 2.8 2020 3.9 2028 Vitamin D3(10) 1.1 2021 1.7 202